• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Graviti`s Generic Hydroxyzine Hydrochloride Receives Approval in the U.S.

    17 Aug 2023 //

    FDA

    Enforcement Report - Week of December 30, 2020

    30 Dec 2020 //

    FDA

    Erfa Canada recalls ATARAX (hydroxyzine) due to resulting in a potential risk

    09 Jun 2016 //

    HEALTH CANADA

    Dr Reddy`s Lab completes acquisition of UCB`s select brands

    19 Jun 2015 //

    BUSINESS TODAY

    Akorn, Inc. initiates Class II recall of Hydroxyzine Hydrochloride due to Failed Impurities/Degradation Specifications

    06 Jun 2015 //

    FDA

    Advanced Physician Solutions, Inc. initiates Class II recall of Hydroxyzine Hydrochloride due to Lack of Assurance of Sterility

    16 May 2015 //

    FDA

    New restrictions to minimise the risks of effects on heart rhythm with hydroxyzine-containing medicines

    27 Mar 2015 //

    EMA

    PRAC recommends new measures to minimise known heart risks of hydroxyzine-containing medicines

    16 Feb 2015 //

    EMA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.